1. AIDS and Intravenous Drug Use;Des Jarlais,1988
2. The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behavior;Hartgers;AIDS,1989
3. Why bleach? Development of a strategy to combat HIV contagion among San Francisco intravenous drug users;Newmeyer,1988
4. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace;Centers for Disease Control;MMWR,1985
5. Disinfection and inactivation of the human T-lymphotropic virus type III/lymphadenopathy-associated virus;Martin;J lnfect Dis,1985